Therapeutic effects and molecular mechanisms of anti-fibrosis herbs and selenium on rats with hepatic fibrosis

World Journal of Gastroenterology

Volumn 10, Issue 5, 2004, Pages 703-706

  He, Yu Tong ^a   Liu, Dian Wu ^a   Ding, Li Yu ^a   Li, Qing ^a   Xiao, Yong Hong ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYDA SINENSIS EXTRACT; ANGELICA SINENSIS EXTRACT; ANTIFIBROTIC AGENT; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CAREX PHACOTA EXTRACT; CD4 ANTIGEN; CD8 ANTIGEN; COLCHICINE; CURCUMA AROMATICA EXTRACT; HERBACEOUS AGENT; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMININ; MESSENGER RNA; PLANT EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SELENIUM; SODIUM CHLORIDE; SPARGANIUM STOLONIFERUM EXTRACT; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYDA SINENSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CAREX PHACOTA; CONTROLLED STUDY; CURCUMA AROMATICA; CYPERACEAE; DRUG INHIBITION; DRUG MECHANISM; FEMALE; FIBROGENESIS; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNITY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LYMPHOCYTE; MALE; MOLECULAR MECHANICS; NONHUMAN; PLANT; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RANDOMIZATION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPARGANIUM STOLONIFERUM; STATISTICAL ANALYSIS;

EID: 1542580378     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i5.703     Document Type: Article

References (36)

1. Missale G, Ferrari C, Fiaccadori F. Cytokine mediators in acute inflammation and chronic course of viral hepatitis. Ann Ital Med Int 1995; 10: 14-18
2. Wang YJ, Sun ZQ. Advance in cytology and molecular biology investigation in liver fibrosis. Xin Xiaohua Bingxue Zazhi 1994; 2: 244-246
3. Wang FS, Wu ZZ. Current situation in studies of gene therapy for liver cirrhosis and liver fibrosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 371-373
4. Zhu YH, Hu DR, Nie QH, Liu GD, Tan ZX. Study on activation and c-fos, c-jun expression of in vitro cultured human hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2000; 8: 299-302
5. Du WD, Zhang YE, Zhai WR, Zhou XM. Dynamic changes of type I, III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis. World J Gastroenterol 1999; 5: 397-403
6. Huang ZG, Zhai WR, Zhang YE, Zhang XR. Study of heteroserum-induced rat liver fibrosis model and its mechanism. World J Gastroenterol 1998; 4: 206-209
7. Jia JB, Han DW, Xu RL, Gao F, Zhao LF, Zhao YC, Yan JP, Ma XH. Effect of endotoxin on fibronectin synthesis of rat primary cultured hepatocytes. World J Gastroenterol 1998; 4: 329-331
8. 1 and traditional medicine preparation. World J Gastroenterol 1999; 5: 267-269
9. Riley TR 3rd, Bhatti AM. Preventive strategies in chronic liver disease: Part II. Cirrhosis. Am Fam Physician 2001; 64: 1735-1740
10. Liu YK, Shen W. Inhibitive effect of cordyceps sinensis on experimental hepatic fibrosis and its possible mechanism. World J Gastroenterol 2003; 9: 529-533
11. Ma X, Qiu DK, Xu J, Zeng MD. Effects of Cordyceps polysaccharides in patients with chronic hepatitis C. Huaren Xiaohua Zazhi 1998; 6: 582-584
12. Yang Q, Yan YC, Gao YX. Inhibitory effect of Quxianruangan Capsulae on liver fibrosis in rats and chronic hepatitis patients. Shijie Huaren Xiaohua Zazhi 2001; 9: 1246-1249
13. You H, Wang B, Wang T. Proliferation and apoptosis of hepatic stellate cells and effects of compound 861 on liver fibrosis. Zhonghua Ganzangbing Zazhi 2000; 8: 78-80
14. Nan JX, Park EJ, Kim YC, Ko G, Sohn DH. Scutellaria baicalensis inhibits liver fibrosis induced by bile duct ligation or carbon tetrachloride in rats. J Pharm Pharmacol 2002; 54: 555-563
15. Wang QC, Shen DL, Zhang CD, Xu LZ, Nie QH, Xie YM, Zhou YX. Effect of Rangansuopiwan in expression of tissue inhibitor of metalloproteinase-1/2 in rat liver fibrosis. Shijie Huaren Xiaohua Zazhi 2001; 9: 379-382
16. Shen M, Qiu DK, Chen Y, Xiong WJ. Effects of recombinant augmenter of liver regeneration protein, danshen and oxymatrine on rat fibroblasts. Shijie Huaren Xiaohua Zazhi 2001; 9: 1129-1133
17. Wang XL, Liu P, Liu CH, Liu C. Effects of coordination of FZHY decoction on functions of hepatocytes and hepatic satellite cells. Shijie Huaren Xiaohua Zazhi 1999; 7: 663-665
18. Yao XX, Tang YW, Yao DM, Xiu HM. Effect of yigan decoction on the expression of type I, III collagen proteins in experimental hepatic fibrosis in rats. Shijie Huaren Xiaohua Zazhi 2001; 9: 263-267
19. Hang M, Song G, Minuk GY. Effects of hepatic stimulator substance, herbal medicine, Selenium/Vitamin E, and ciproloxacin on cirrhosis in the rat. Gastroenterology 1996; 110: 1150-1155
20. Buljcbac M, Roimic Z, Vucclic B. Serum selenium concentration in patients with liver cirrhosis hepatocellular carcinoma. Acta Med Crearice 1996; 50: 11-15
21. Weng HL, Cai WM, Liu RH. Animal experiment and clinical study of effect of gamma interferon on hepatic fibrosis. World J Gastroenterol 2001; 7: 42-48
22. Li BS, Wang J, Zhen YJ, Liu JX, Wei MX, Sun SQ, Wang SQ. Experimental study on serum fibrosis markers and liver tissue pathology and hepatic fibrosis in immuno-damaged rats. Shijie Huaren Xiaohua Zazhi 1999; 7: 1031-1034
23. Bissell DM. Chronic liver injury, TGF-beta, and cancer. Exp Mol Med 2001; 33: 179-190
24. Friedman SL. Cytokines and fibrogenesis. Semin Liver Dis 1999; 19:129-140
25. Chen WX, Li YM, Yu CH, Cai WM, Zheng M, Chen F. Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease. World J Gastroenterol 2002; 8: 379-381
26. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002; 7: D793-807
27. Lewindon PJ, Pereira TN, Hoskins AC, Bridle KR, Williamson RM, Shepherd RW, Ramm GA. The role of hepatic stellate cells and transforming growth factor-beta (1) in cystic fibrosis liver disease. Am J Pathol 2002; 160: 1705-1715
28. Beraud C, Henzel WJ, Baeuerle PA. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation. Proc Natl Acad Sci U S A 1999; 96: 429-434
29. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. Identification and characterization of an IκB kinase. Cell 1997; 90: 373-383
30. Zandi E, Karin M. Bridging the gap: Composition, regulation, and physiological function of the IκB kinase complex. Mol Cell Biom 1999; 19: 4547-4551
31. May MJ, Ghosh S. IκB kinases: Kinsmen with different crafts. Science 1999; 284: 271-273
32. Baeuerle PA. IκB-NF-κB structures: At the interface of inflammation control. Cell 1999; 95: 729-731
33. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141-179
34. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-κB activation by tumour necrosis factor requires the Akt serine -threonine kinase. Nature 1999; 401: 83-85
35. Romashkova JA, Makarov SS. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999; 401: 86-90
36. Hinz M, Krappmann D, Eichten A, Scheidereit C, Strauss M. NF-κB function in growth control: Regulation of cyclin D1 expression and G0-G1-to-S-phase transition. Mol Cell Biol 1999; 19: 2690-2698